InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,616.80
(
0.04%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.87
(
-0.73%
)
Bitcoin
62,305.46
(
-1.36%
)
Post# of 492
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

7Card

Send PM Follow Ignore
Followers 5
Posts 861
Boards Moderated 0
Alias Born 02/23/2017

7Card

Re: None

Monday, 05/06/2019 1:42:22 PM

Monday, May 06, 2019 1:42:22 PM

Post# of 492
LexaGene’s Technology Identifies Genetic Mutations Directly from Cheek Swabs. Another huge market. $6Billion

LexaGene has demonstrated the ability for the same technology to be used for personal genotyping, which has a market value of greater than $6 B. The applications for genotyping (i.e. understanding genetic sequences in areas of scientific/clinical importance) are vast, including research focused on cancer and neurological diseases, as well as pharmacogenomic testing to determine a person’s genetic response to medication.

https://finance.yahoo.com/news/lexagene-technology-identifies-genetic-mutations-115500510.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up